← Open Payments lookup

MARCY MARKES: Open Payments

NPI 1962683995 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$14,150 in 160 payments from 22 companies in 2025. Trend: 2023 $23,786 · 2024 $19,154 · 2025 $14,150

Speaker / faculty: $6,394Food & beverage: $4,140Consulting: $2,646Travel & lodging: $880Education: $90
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP44$4,499
GENZYME CORPORATION21$3,812
Grifols USA, LLC15$2,489
Novartis Pharmaceuticals Corporation17$1,730
Regeneron Healthcare Solutions, Inc.10$256
Takeda Pharmaceuticals U.S.A., Inc.7$249
Incyte Corporation2$159
Genentech USA, Inc.6$119
Lilly USA, LLC6$113
ARS Pharmaceuticals Operations, Inc.6$112

Products named: FASENRA, DUPIXENT, Prolastin-C Liquid, TEZSPIRE, AIRSUPRA, Xolair, EBGLYSS, NEFFY.

Industry payments across MO — which companies pay providers there.